231
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Bent-shaped mesogenic oxadiazole and thiadiazole derivatives from rod-shaped mesogenic hydrazide containing polar chloro group

&
Pages 407-415 | Received 03 Dec 2009, Accepted 18 Jan 2010, Published online: 23 Apr 2010
 

Abstract

Rod-shaped mesogenic hydrazide (series I) derivatives have been synthesised by the Schotten-Baumann reaction of 4-chlorobenzhydrazide with 4-n-alkoxybenzoyl chloride using pyridine as a solvent. Rod-shaped mesogenic hydrazide (series I) have been cyclised to bent-shaped mesogenic oxadiazole (series II) and thiadiazole (series III) derivatives using POCl3 and P2S5, respectively. The synthesised compounds are characterised by a combination of elemental analysis and standard spectroscopic methods. All the compounds of present series I–III exhibit smectic A mesophase. The mesomorphic properties of the present series I–III are compared with each other and with the other structurally related mesogenic homologous series to evaluate the effect of bent-shape and different heterocyclic moiety on mesomorphism.

Acknowledgements

The authors thank the Dean, Faculty of Technology and Engineering, and Head, Applied Chemistry Department, for providing the research facilities.

Notes

This paper was presented at the 16th National Conference on Liquid Crystals (NCLC-2009) held at Department of Physics, University of Lucknow, Lucknow, 26–28 October 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.